Publications 2026

Solli E, Bevilacqua A, Wenes M, Migliorini D, van der Veen L, Skånland SS, Di Conza G, Taskén K (2026)
The PI3Kδ inhibitor roginolisib (IOA-244) preserves T-cell function and activity
Mol Oncol, 20 (6), 1612-1625
DOI 10.1002/1878-0261.70203, PubMed 41568714

Wei Q, Hajjar E, Cornillot-Clément S, Solli E, García-Díaz N, Landskron J, Gade A, Ahmad R, Taskén K (2026)
High-Throughput Phenotypic Screen to Identify FoxP3 Regulators in Primary T Cells
ACS Chem Biol, 21 (4), 764-778
DOI 10.1021/acschembio.5c01019, PubMed 41930720

Publications 2025

García-Díaz N, Solli E, Hajjar E, Cornillot-Clément S, Landskron J, Ahmad R, Wei Q, Taskén K (2025)
MAPK and STAT3 Inhibitors Modulate FoxP3 Expression and Regulatory T Cell Function
Eur J Immunol, 55 (2), e202451225
DOI 10.1002/eji.202451225, PubMed 39955647

Publications 2023

Brynjulvsen M, Solli E, Walewska M, Zucknick M, Djirackor L, Langmoen IA, Mughal AA, Skaga E, Vik-Mo EO, Sandberg CJ (2023)
Functional and Molecular Heterogeneity in Glioma Stem Cells Derived from Multiregional Sampling
Cancers (Basel), 15 (24)
DOI 10.3390/cancers15245826, PubMed 38136371